{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:12:05Z","timestamp":1784970725154,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pharma.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T10:54:08Z","timestamp":1646045648000},"page":"853-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates"],"prefix":"10.1016","volume":"80","author":[{"given":"Samaresh","family":"Pal Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Kadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipulkumar V","family":"Karkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa","family":"Rao Konijeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2022.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Trans N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0895-4356(01)00425-5","article-title":"Risk tables for Parkinsonism and Parkinson's disease","volume":"55","author":"Elbaz","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.pharma.2022.02.007_bib0155","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/oem.2006.027003","article-title":"Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study","volume":"64","author":"Dick","year":"2007","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.pharma.2022.02.007_bib0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease\u201d","volume":"55","author":"Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7 Supplement 2","key":"10.1016\/j.pharma.2022.02.007_bib0165","first-page":"S12","article-title":"Diagnosis and the premotor phase of Parkinson disease","volume":"72","author":"Tolosa","year":"2009","journal-title":"Neurology (ECronicon)"},{"issue":"4","key":"10.1016\/j.pharma.2022.02.007_bib0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.pharma.2022.02.007_bib0175","first-page":"525","article-title":"Epidemiology of Parkinson's disease. The Lancet","volume":"5","author":"De Lau","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2022.02.007_bib0180","series-title":"Symptomatic pharmacological therapy in Parkinson's disease. Parkinson's Disease","first-page":"59","author":"National Collaborating Centre for Chronic","year":"2006"},{"issue":"4417","key":"10.1016\/j.pharma.2022.02.007_bib0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.504992","article-title":"Movement disorders of aged rats: reversal by dopamine receptor stimulation","volume":"206","author":"Marshall","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.pharma.2022.02.007_bib0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.fitote.2012.12.009","article-title":"Recent advances in herbal medicines treating Parkinson's disease","volume":"84","author":"Li","year":"2013","journal-title":"Fitoterapia"},{"issue":"13","key":"10.1016\/j.pharma.2022.02.007_bib0195","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.phytochem.2004.06.012","article-title":"Constituents from the bark of Tabebuia impetiginosa","volume":"65","author":"Warashina","year":"2004","journal-title":"Phytochemistry"},{"issue":"5701","key":"10.1016\/j.pharma.2022.02.007_bib0200","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1126\/science.1104812","article-title":"The ethylene signaling pathway","volume":"306","author":"Alonso","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2008.10.004","article-title":"Red Lapacho (Tabebuia impetiginosa)\u2014a global ethnopharmacological commodity?","volume":"121","author":"Castellanos","year":"2009","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"10.1016\/j.pharma.2022.02.007_bib0210","doi-asserted-by":"crossref","first-page":"22863","DOI":"10.3390\/molecules201219885","article-title":"Bioactive properties of Tabebuia impetiginosa-based phytopreparations and phytoformulations: a comparison between extracts and dietary supplements","volume":"20","author":"Pires","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/jf020811h","article-title":"Antioxidant activity and characterization of volatile constituents of Taheebo (Tabebuia impetiginosa Martius ex DC)","volume":"51","author":"Park","year":"2003","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.pharma.2022.02.007_bib0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13596-014-0149-3","article-title":"Antioxidant and antiparkinsonian activity of Passiflora incarnata leaves","volume":"14","author":"Ingale","year":"2014","journal-title":"Orient Pharm Exp Med."},{"issue":"7-8","key":"10.1016\/j.pharma.2022.02.007_bib0225","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1515\/znc-2003-7-809","article-title":"Naphthoquinone derivatives and lignans from the Paraguayan crude drug \u201ctay\u00ef pyt\u00e1\u201d (Tabebuia heptaphylla, Bignoniaceae)","volume":"58","author":"Schmeda-Hirschmann","year":"2003","journal-title":"Z Naturforsch C J Biosci"},{"issue":"2","key":"10.1016\/j.pharma.2022.02.007_bib0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4062\/biomolther.2018.234","article-title":"Neuroprotective effect of \u03b2-lapachone in MPTP-induced Parkinson's disease mouse model: involvement of astroglial p-AMPK\/Nrf2\/HO-1 signaling pathways","volume":"27","author":"Park","year":"2019","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.pharma.2022.02.007_bib0235","series-title":"The practical evaluation of phytopharmaceuticals","author":"Brain","year":"1975"},{"issue":"2","key":"10.1016\/j.pharma.2022.02.007_bib0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Exp Neurol"},{"issue":"9","key":"10.1016\/j.pharma.2022.02.007_bib0245","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1037\/h0077266","article-title":"Olfactory recognition of conspecifics by domestic Norway rats","volume":"90","author":"Carr","year":"1976","journal-title":"J Comp Physiol Psychol"},{"issue":"1\u20133","key":"10.1016\/j.pharma.2022.02.007_bib0250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejphar.2005.12.032","article-title":"Pilocarpine improves olfactory discrimination and social recognition memory deficits in 24 month-old rats","volume":"531","author":"Prediger","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharma.2022.02.007_bib0255","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.pharma.2022.02.007_bib0260","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/0006-2952(74)90235-4","article-title":"A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue","volume":"23","author":"Schlumpf","year":"1974","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0265","first-page":"190","article-title":"Determination of brain biogenic amines in Cynodondactylon Pers. and Cyperus rotundus L. treated mice","volume":"1","author":"Pal","year":"2009","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0270","first-page":"190","article-title":"Lapachol and lapachone analogs: a journey of two decades of patent research (1997-2016)","volume":"1","author":"Hussain","year":"2009","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10.1016\/j.pharma.2022.02.007_bib0275","doi-asserted-by":"crossref","first-page":"e1478","DOI":"10.1371\/journal.pntd.0001478","article-title":"A \u201cgenome-to-lead\u201d approach for insecticide discovery: pharmacological characterization and screening of Aedes aegypti D 1-like dopamine receptors","volume":"6","author":"Meyer","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.pharma.2022.02.007_bib0280","doi-asserted-by":"crossref","first-page":"22863","DOI":"10.3390\/molecules201219885","article-title":"Bioactive properties of Tabebuia impetiginosa-based phytopreparations and phytoformulations: a comparison between extracts and dietary supplements","volume":"20","author":"Pires","year":"2015","journal-title":"Molecules"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092200030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092200030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:36:19Z","timestamp":1757720179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000345092200030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S000345092200030X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2022.02.007","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}